Sildenafil Tablet
Product Images NDC 71335-1963

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71335-1963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713351963)

Sildenafil Citrate 20 mg tablet label showing a white round tablet, packaged by Bryant Ranch Prepack in Burbank, CA. The label notes comparison to Revatio 20 mg tablet by Ajanta Pharma Limited. Storage instructions specify room temperature 20°-25°C (68°-77°F), with warnings to keep out of reach of children. The NDC is 71335-1963-1.*

FDA Label Image

Figure1 (Sildenafil Figure 1)

A line graph depicting the estimated cumulative mortality rate over a 5-year period for three dose levels: High Dose, Medium Dose, and Low Dose. The x-axis represents time in years, while the y-axis shows the mortality rate percentage. The graph includes stepwise lines for each dose, with High Dose showing the highest increase in mortality rate, Medium Dose intermediate, and Low Dose the lowest. A table above the graph shows the number of subjects at risk at various time points for each dose group.*

FDA Label Image

Sildenafil_fig2 (Sildenafil Figure 2)

A scientific chart showing the fold change and 90% confidence interval of AUC and Cmax for various drugs interacting with Sildenafil. The chart includes drugs such as Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, oral contraceptives, Ritonavir, and Saquinavir, along with recommendations on dose adjustments or coadministration advisories.*

FDA Label Image

Figure3 (Sildenafil Figure 3)

A forest plot chart showing fold changes with 90% confidence intervals for various interacting drugs including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, different doses of Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. The chart compares parameters such as INR, AUC, Cmax, BT, with recommendations on dose adjustments, mostly indicating 'No dose adjustment' except for Ritonavir which is marked as 'Coadministration not recommended'.*

FDA Label Image

Figure4 (Sildenafil Figure 4)

A line chart showing change from baseline in meters over weeks 4, 8, and 12 of a study. The chart compares placebo and three Sildenafil doses (20 mg TID, 40 mg TID, 80 mg TID), with data points and error bars for each week, depicting the effect of Sildenafil dosage on distance change over time.*

FDA Label Image

Figure5 (Sildenafil Figure 5)

A forest plot chart showing placebo-corrected changes in 6-minute walk distance (in meters) with Sildenafil 20 mg TID across various patient subgroups. The x-axis measures change from -20 to 40 meters. Subgroups include baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean PAP, and PVRI, each with data points and confidence intervals comparing Sildenafil and placebo groups.*

FDA Label Image

Figure6 (Sildenafil Figure 6)

A line graph comparing the percentage of subjects without a clinically worsening event over time between Sildenafil and placebo groups. The x-axis represents days from randomization, and the y-axis shows the percentage without clinically worsening events. The Sildenafil group maintains a higher percentage over 112 days compared to placebo.*

FDA Label Image

Sildenafil-figure-7 (Sildenafil Figure 7)

A line chart showing mean change from baseline (meters) on the y-axis versus week of study on the x-axis at weeks 4, 8, and 12. It compares Sildenafil tablets at 1 mg, 5 mg, and 20 mg doses taken three times daily (TID), with standard error bars for each dose and visit.*

FDA Label Image

Structure (Sildenafil Structure)

Chemical structure of Sildenafil as shown in the molecular diagram. The image includes rings, alkyl groups, sulfonamide, and carboxylic acid moieties consistent with the Sildenafil molecule's known structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.